Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancer (Q35791273)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2004
edit
Language Label Description Also known as
English
Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancer
scientific article published on April 2004

    Statements

    Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit